Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorCivaTech Oncology

About this trial

This is a feasibility study to determine the usefulness of a brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit lung cancer patients by reducing the radiation dose to critical structures, such as the heart wall, while giving a therapeutic dose to diseased tissue, such as at a surgical margin.

Eligibility criteria

Qualifiers

Subject signed inform consent

Suspected or proven non-small cell lung cancer (NSCLC) in the upper lobes of the left or right lung

Pre-operative criteria

Lung nodule suspicious for NSCLC

Disqualifiers

None

Trial design

Treatments tested in this trial

  • CivaSheet

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators